Overview

What they do
Launched in February 2020, AurorA Science is a specialized biotech investment company formed through a partnership between the technology transfer firm AurorA-TT and two strategic industrial investors: Rottapharm Biotech and Italfarmaco. It focuses on independent, entrepreneurial biotech start-ups with high therapeutic potential. What makes AurorA Science distinctive is its "industrial approach"-it offers portfolio companies direct access to the in-house R&D facilities, scientists, and drug development expertise of its corporate partners to de-risk projects and accelerate preclinical and early clinical development.
aurorascience.eu
What they look for
AurorA Science aims to bridge the gap between basic research and industrial drug development. They focus on supporting independent and entrepreneurial biotech start-ups in Europe with high therapeutic potential, translating cutting-edge science into patient care.
aurorascience.eu
Stage
Pre-seed, Series A
aurorascience.eu
Sectors
Healthcare, Deeptech
aurorascience.eu
Based
Milan, IT
aurorascience.eu

Sources

2026-09-02aurorascience.euAurorA Science is a biotech investment company integrating an innovative financial and…
2026-09-02aurorascience.euInteRNA is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA…
2026-09-02aurorascience.euDo you want to turn a dream into a therapy? Contact Us to discuss
2026-09-02aurorascience.euGUIDO GUIDI, MD CHAIRMAN

Portfolio, cheque size and the rest

The 2 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.

Start free, no cardFree accounts see every record.